INTERREG 2 Seas – IMODE – Innovative MulticOmponent Drug dEsign (Advanced materials and pharmaceutical technologies)



  • Reinforce R&D by designing innovative drugs and medical devices, ready to use and patentable, based on new multi-component materials with enhanced therapeutic properties
  • Ensure the knowledge transfer to provide a high-qualified labor force (scientists and technicians from both academic and industrial community, students)

Activities carried out by Eurasanté:

  • Technological transfer
  • Communication activities, building a network and organizing events
  • Provide a support in medical, marketing, training and networking fields

Duration: 48 months

Official start: from 01/07/2016 to 30/06/2021

Budget: € 5 910 275

Head of project: University of Lille – Sciences and Technologies – FR

  • Eurasanté (FR)
  • University of Lille – Faculty of medicine (FR)
  • ImaBiotech (FR)
  • Roquette Frères (FR)
  • University College of London (UK)
  • University of East Anglia (UK)
  • University of Greenwich (UK)
  • Ashford and St. Peter’s Hospitals NHS Foundation Trust (UK)
  • Cubic Pharmaceutical Ltd (UK)
  • University of Ghent (BE)

With the support of the European Regional Development Fund